Cargando…
Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
BACKGROUND: Recent directions in the treatment of ADHD have involved both a broadening of pharmacological perspectives to include nor-adrenergic as well as dopaminergic agents. A review of animal and human studies of pharmacological and therapeutic directions in ADHD suggests that the D1 receptor is...
Autor principal: | Levy, Florence |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289834/ https://www.ncbi.nlm.nih.gov/pubmed/18304369 http://dx.doi.org/10.1186/1744-9081-4-12 |
Ejemplares similares
-
Vigilance, Inhibitory Control and Regional Cerebral Blood Oxygenation in the PFC - Differences in ADHD Types of Presentations
por: Skalski, Sebastian, et al.
Publicado: (2020) -
Activity in dlPFC and its effective connectivity to vmPFC are associated with temporal discounting
por: Hare, Todd A., et al.
Publicado: (2014) -
Pharmacological approaches of ADHD
por: Cooper, R., et al.
Publicado: (2021) -
Once-daily medications for the pharmacological management of ADHD in adults
por: Tcheremissine, Oleg V, et al.
Publicado: (2009) -
Characterization of Pediococcus acidilactici PFC69 and Lactococcus lactis PFC77 Bacteriocins and Their Antimicrobial Activities in Tarhana Fermentation
por: Kaya, Halil İbrahim, et al.
Publicado: (2020)